Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-100908
Filing Date
2025-07-31
Accepted
2025-07-31 16:12:38
Documents
85
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q opk-20250630.htm   iXBRL 10-Q 4687762
2 EX-31.1 opk-ex31_1.htm EX-31.1 14383
3 EX-31.2 opk-ex31_2.htm EX-31.2 14383
4 EX-32.1 opk-ex32_1.htm EX-32.1 6141
5 EX-32.2 opk-ex32_2.htm EX-32.2 6146
  Complete submission text file 0000950170-25-100908.txt   18951116

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT opk-20250630.xsd EX-101.SCH 1879958
87 EXTRACTED XBRL INSTANCE DOCUMENT opk-20250630_htm.xml XML 4551106
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 251171805
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)